Watson news

Sanofi, Watson Resolve Patent Dispute Over Plavix

IP Law360 - 57 minutes ago
Law360, New York (August 12, 2009) -- Sanofi-Aventis has reached a deal with Watson Pharmaceuticals Inc. in a long-standing patent infringement suit over Watson's attempt to market a generic ...

Watson Pharmaceuticals (WPI) Bullish Technical Alert - Trend Up 18.2%

Comtex Smartrend - 11 minutes ago
By Chip Brian, SmarTrend Analytics Team Watson Pharmaceuticals (NYSE:WPI) is trading 0.9% higher (up $0.32 to $34.62) today on volume of 54,488 shares. The stock is trading near its 52-week high ...

Watson Pharmaceuticals and Arrow Group Receive FTC Second Request

PR-USA.net - 7 hours ago
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today announced that it has received a request for additional information from the Federal Trade Commission ("FTC") in ...

FTC Seeks More Info On Watson, Arrow Merger

Competition Law 360 - 7 hours ago
Law360, New York (August 07, 2009) -- The Federal Trade Commission has issued a second request to Watson Pharmaceuticals Inc. for more information regarding its proposed merger with generics maker ...

Watson Announces Limited Recall Of Fentanyl Transdermal System

Watson Says FDA May Approve Generic Toprol-Xl Soon

FDA news - 5 hours ago
Watson Pharmaceuticals, which reported a 9 percent increase in second-quarter sales compared with the same quarter last year, may win approval soon for certain generic versions of AstraZeneca's ...

Watson Pharmaceuticals and Arrow Group Receive FTC Second Request

Watson Pharma says FDA approved generic Toprol XL

Toprol OK's a boon for Watson amid shortage

FiercePharma - 14 minutes ago
Watson Pharmaceuticals could reap big benefits from the approval of its version of the blood pressure med Toprol XL, because two rival generic drugs were suspended because of manufacturing ...

Watson Pharmaceuticals Inc. Reports Operating Results (10-Q)

GuruFocus.com - 18 minutes ago
Watson Pharmaceuticals Inc. is a pharmaceutical company primarily engagedin the development production marketing and distribution of both branded and off-patent pharmaceutical products. The ...